Literature DB >> 18508566

The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.

Yue Chen1, Randy Y C Poon.   

Abstract

Cell cycle checkpoints are pivotal mechanisms safeguarding genome stability. Cells that harbor defects in checkpoints are predisposed to genome instability and neoplastic transformation. Two structurally-unrelated protein kinases, CHK1 and CHK2, are implicated in several major checkpoints of the cell cycle, providing a crucial linkage between the upstream sensors of the checkpoints and the cell cycle engine. Variations of the ATM/ATR-CHK1/CHK2-CDC25-CDK axis underlie the molecular basis of the replication checkpoint, the intra-S phase checkpoint, and the G2 DNA damage checkpoint. Although some aspects of the pathway remain contentious, the ATM/ATR-CHK1/CHK2-p53-p21CIP1/WAF1-CDK axis is believed to play an important role in the G1 DNA damage checkpoint. Recent data also reveal that CHK1 may play a role in the spindle-assembly checkpoint. Finally, CHK1 and CHK2 are implicated in linking the cell cycle to diverse processes such as senescence and the circadian cycle. In this review article, we provide an overview of how the multi-tasking nature of CHK1 and CHK2 is achieved in vertebrate cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508566     DOI: 10.2741/3060

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  54 in total

1.  Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2008-10-06       Impact factor: 4.534

Review 2.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

3.  Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.

Authors:  Pankaj Kumar; Masanao Murakami; Rajeev Kaul; Abhik Saha; Qiliang Cai; Erle S Robertson
Journal:  Future Virol       Date:  2009-01       Impact factor: 1.831

4.  MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway.

Authors:  Ralph Gruber; Zhongwei Zhou; Mikhail Sukchev; Tjard Joerss; Pierre-Olivier Frappart; Zhao-Qi Wang
Journal:  Nat Cell Biol       Date:  2011-09-25       Impact factor: 28.824

5.  Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism.

Authors:  Hajar Fahkri; Bingbing Zhang; Abul Fajol; Nati Hernando; Bernat Elvira; Julia G Mannheim; Bernd J Pichler; Christoph Daniel; Kerstin Amann; Atsushi Hirao; Jillian Haight; Tak W Mak; Florian Lang; Michael Föller
Journal:  Pflugers Arch       Date:  2014-10-17       Impact factor: 3.657

6.  PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpoints.

Authors:  Zhoushuai Qin; Zhiqiang Bai; Ying Sun; Xiaohong Niu; Wei Xiao
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

7.  Interdependent phosphorylation within the kinase domain T-loop Regulates CHK2 activity.

Authors:  Xin Guo; Michael D Ward; Jessica B Tiedebohl; Yvonne M Oden; Julius O Nyalwidhe; O John Semmes
Journal:  J Biol Chem       Date:  2010-08-16       Impact factor: 5.157

8.  Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase.

Authors:  Halfdan Beck; Viola Nähse; Marie Sofie Yoo Larsen; Petra Groth; Trevor Clancy; Michael Lees; Mette Jørgensen; Thomas Helleday; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

9.  RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.

Authors:  C F Wu; S Liu; Y-C Lee; R Wang; S Sun; F Yin; W G Bornmann; L-Y Yu-Lee; G E Gallick; W Zhang; S-H Lin; J Kuang
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

10.  14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.

Authors:  Siwei Tang; Chen Bai; Pengyuan Yang; Xian Chen
Journal:  J Proteome Res       Date:  2013-05-09       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.